Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Microparticle Platform
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
IgM antibody identifies good candidates for natalizumab
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Intermittent Atrioventricular Block following Fingolimod Initiation.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
Sleep-disordered breathing in multiple sclerosis.
Pages
« first
‹ previous
…
193
194
195
196
197
198
199
200
201
…
next ›
last »